GRACEcast
ASCO Lung Cancer Highlights, Part 13: The Immune Checkpoint Inhibitor MPDL3280A in Advanced NSCLC (audio)
- Author: Podcast
- Narrator: Podcast
- Publisher: Podcast
- Duration: 0:05:27
- More information
Informações:
Synopsis
Dr. Edward Garon, David Geffen School of Medicine at UCLA, covers the provocative results of the novel immune checkpoint PD-L1 inhibitor MPDL3280A in advanced NSCLC.
